Work

TGR-1202: A Novel, Targeted PI3Kδ Inhibitor in Multiple Myeloma

Year: 2012

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood.v120.21.5018.5018

Authors: Swaroop Vakkalanka, Srikant Viswanadha, Lawrence H. Boise, Peter Sportelli, Hari Miskin, Sagar Lonial

Institutions: Rhizen Pharmaceuticals (Switzerland), Winship Cancer Institute, TG Therapeutics, Inc. (United States)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2552063523

Cites:

Cited by:

Related to: 10